[go: up one dir, main page]

MX2017011220A - Metodos para hacer celulas madre neurales y usos de las mismas. - Google Patents

Metodos para hacer celulas madre neurales y usos de las mismas.

Info

Publication number
MX2017011220A
MX2017011220A MX2017011220A MX2017011220A MX2017011220A MX 2017011220 A MX2017011220 A MX 2017011220A MX 2017011220 A MX2017011220 A MX 2017011220A MX 2017011220 A MX2017011220 A MX 2017011220A MX 2017011220 A MX2017011220 A MX 2017011220A
Authority
MX
Mexico
Prior art keywords
neural stem
cell
methods
stem cells
days
Prior art date
Application number
MX2017011220A
Other languages
English (en)
Inventor
D Hingtgen Shawn
Dumitru Raluca
Rodriguez Bago Julio
Original Assignee
Univ North Carolina Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina Chapel Hill filed Critical Univ North Carolina Chapel Hill
Publication of MX2017011220A publication Critical patent/MX2017011220A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/09—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

De acuerdo con algunas modalidades, aquí­ se proporciona un método para producir una cólula madre neural inducida (CMNi), cuyo método puede incluir una o más etapas de: proporcionar una cólula somática; introducir en (por ejemplo, mediante transfección o transacción) dicha cólula somática con un ácido nucleico que codifica Sox2, con el que dicha cólula expresa Sox2; y despuós transdiferenciar dicha cólula somática (por ejemplo al cultivar la cólula en un medio progenitor neural), para producir así­ dicha cólula madre neural; en algunas modalidades, la transdiferenciación se lleva a cabo durante un tiempo de 1 a 10 dí­as, de 1 a 5 dí­as, de 1 a 3 dí­as o de 12 a 24 o 48 horas.
MX2017011220A 2015-03-04 2016-03-03 Metodos para hacer celulas madre neurales y usos de las mismas. MX2017011220A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562128247P 2015-03-04 2015-03-04
PCT/US2016/020649 WO2016141162A1 (en) 2015-03-04 2016-03-03 Methods for making neural stem cells and uses thereof

Publications (1)

Publication Number Publication Date
MX2017011220A true MX2017011220A (es) 2018-07-06

Family

ID=56848639

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011220A MX2017011220A (es) 2015-03-04 2016-03-03 Metodos para hacer celulas madre neurales y usos de las mismas.

Country Status (12)

Country Link
US (1) US20180051249A1 (es)
EP (1) EP3265556A4 (es)
JP (1) JP2018508216A (es)
KR (1) KR20170133373A (es)
CN (1) CN107849538A (es)
AU (1) AU2016226203A1 (es)
BR (1) BR112017018704A2 (es)
CA (1) CA2978086A1 (es)
IL (1) IL254156A0 (es)
MX (1) MX2017011220A (es)
SG (1) SG11201707047VA (es)
WO (1) WO2016141162A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2978109A1 (en) 2015-03-31 2016-10-06 The University Of North Carolina At Chapel Hill Delivery vehicles for stem cells and uses thereof
CN106806894B (zh) * 2015-12-01 2021-06-25 海门雨霖细胞科技有限责任公司 小分子组合物诱导人肿瘤细胞直接重编程为非致瘤性细胞的方法
CN108949687A (zh) * 2018-07-24 2018-12-07 九三极恒生物医药科技江苏有限公司 诱导多能干细胞向运动神经细胞分化的无血清培养体系
CN108893444A (zh) * 2018-07-24 2018-11-27 九三极恒生物医药科技江苏有限公司 诱导多能干细胞向皮层神经细胞分化的无血清培养体系
CN108823164A (zh) * 2018-07-24 2018-11-16 九三极恒生物医药科技江苏有限公司 诱导多能干细胞向神经祖细胞分化的无血清培养体系
WO2020056521A1 (en) 2018-09-20 2020-03-26 Mystem Biotechnologies Inc. Colostrum derived stem cells, neural differentiation, compositions and supplements for enhancing mammalian health
US20220235331A1 (en) * 2019-04-17 2022-07-28 Keio University Production method and kit of induced pluripotent stem cells
WO2020242212A1 (ko) * 2019-05-29 2020-12-03 성균관대학교산학협력단 신규한 유사신경교세포 제조용 칵테일 조성물, 이를 이용하여 제조된 신규한 유사신경교세포, 이의 제조 방법 및 이를 포함하는 신경 질환 예방 또는 치료용 세포 치료제
US12494279B2 (en) * 2020-10-02 2025-12-09 Datma, Inc. System and method for data visualization
CN116144596A (zh) * 2021-03-26 2023-05-23 广西大学 一种体外高效诱导人体细胞重编程为神经元细胞的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021437A1 (en) * 2008-04-07 2010-01-28 The McLean Hospital Corporation Whitehead Institute for Biomedical Research Neural stem cells derived from induced pluripotent stem cells
JP5608645B2 (ja) * 2008-11-05 2014-10-15 学校法人慶應義塾 神経幹細胞製造方法
US20120207744A1 (en) * 2009-03-19 2012-08-16 Mendlein John D Reprogramming compositions and methods of using the same
JP2013521760A (ja) * 2010-03-10 2013-06-13 国立大学法人京都大学 人工多能性幹細胞の選別方法
EP2606126B1 (en) * 2010-08-19 2016-05-18 F.Hoffmann-La Roche Ag Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)
CN102604894B (zh) * 2012-02-29 2014-07-30 中国科学院广州生物医药与健康研究院 用于制备神经干细胞的培养基及其用途
CA2978109A1 (en) * 2015-03-31 2016-10-06 The University Of North Carolina At Chapel Hill Delivery vehicles for stem cells and uses thereof

Also Published As

Publication number Publication date
JP2018508216A (ja) 2018-03-29
SG11201707047VA (en) 2017-09-28
EP3265556A4 (en) 2018-08-22
EP3265556A1 (en) 2018-01-10
CN107849538A (zh) 2018-03-27
US20180051249A1 (en) 2018-02-22
BR112017018704A2 (pt) 2018-04-17
KR20170133373A (ko) 2017-12-05
IL254156A0 (en) 2017-10-31
WO2016141162A1 (en) 2016-09-09
AU2016226203A1 (en) 2017-10-05
CA2978086A1 (en) 2016-09-09

Similar Documents

Publication Publication Date Title
MX2017011220A (es) Metodos para hacer celulas madre neurales y usos de las mismas.
EP4345160A3 (en) Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells
MY189778A (en) Method for producing retinal pigment epithelial cells
HK1257341A1 (zh) 硷性磷酸酯的制造
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
AR102888A1 (es) Animales no humanos que tienen un gen humanizado de agrupamiento de diferenciación 47
MY156588A (en) Systems using cell culture for production of isoprene
BR112015019950A2 (pt) Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
WO2017051347A3 (en) Cells and method of cell culture
SG10201900323SA (en) Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
MX2018004366A (es) Aislamiento temprano post-transfeccion de celulas (epic) para la produccion de productos biologicos.
BR112021008738A2 (pt) Processo para produzir células t geneticamente construídas
MX2016005658A (es) Suspensión y agrupamiento de células madre humanas pluripotentes para la diferenciación a células endocrinas pancreáticas.
MX2019010575A (es) Metodo para producir anticuerpos multiespecificos.
MX2023003296A (es) Generacion de lineas de cardiomiocitos auriculares y ventriculares a partir de celulas madre pluripotentes humanas.
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
MY193954A (en) Method for manufacturing ciliary margin stem cells
WO2016007570A3 (en) Engineered invariant natural killer t (inkt) cells and methods of making and using thereof
MY191776A (en) Method for preparing electrocompetent yeast cells, and method for using said cells
MY199613A (en) Cell population for transplantation and method for producing same
MY184796A (en) Method for manufacturing ciliary marginal zone-like structure
WO2014027176A3 (en) Stem cell culture method
WO2015073625A3 (en) Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors